Functional motor performance and reliability of the Dubousset Functional Test in ambulatory children with spastic cerebral palsy

dc.contributor.authorErgun, Betul
dc.contributor.authorBaykan, Muge
dc.contributor.authorCopuroglu, Ozge Baykan
dc.contributor.authorAbakay, Hanife
dc.contributor.authorGuc, Ayse
dc.contributor.authorKarabulut, Ridvan
dc.date.accessioned2026-08-12T17:28:29Z
dc.date.issued2026
dc.departmentFırat Üniversitesi
dc.description.abstractBackgroundCerebral palsy (CP) causes permanent motor impairments, limiting postural control and mobility. The Dubousset Functional Test (DFT) was developed to assess daily activity performance, but its reliability and validity in pediatric CP are unclear. This study aimed to evaluate its reliability, convergent and discriminative validity, and clinical utility in children with spastic CP at GMFCS Levels I - II. MethodsThirty-three children aged 6-15 years with spastic CP (GMFCS I - II) participated in this cross-sectional methodological study. The DFT (Rise-and-Walk, Step, Sit-to-Stand, and Dual Task subtests) was administered along with the Timed Up and Go (TUG), Dual-task TUG, 3-Meter Backward Walk Test (3MBWT), Functional Reach Test (FRT), and Pediatric Balance Scale (PBS). All assessments were conducted twice, seven days apart, by a single experienced physiotherapist. ResultsThe DFT demonstrated excellent reliability, with ICC(3,2) values ranging from 0.91 to 0.95 and minimal measurement bias (-0.61 to 0.36 s). The smallest detectable change (SDC) ranged from 2.1 to 13.0 s, confirming high measurement precision. Strong correlations were observed between the DFT Dual Task and both TUG (r = 0.95, p < .001) and Dual-task TUG (r = 0.95, p < .001), supporting convergent validity. ROC analysis indicated excellent discriminative accuracy for identifying children with balance limitations (PBS < 45) (AUC = 0.82, sensitivity = 0.81, specificity = 0.78). ConclusionThe DFT is a reliable, valid, and clinically feasible tool for assessing balance and mobility in ambulatory children with spastic CP at GMFCS I - II, supporting routine rehabilitation use. Trial RegistrationClinicalTrials.gov (NCT06831591).
dc.identifier.doi10.1080/17518423.2026.2626754
dc.identifier.issn1751-8423
dc.identifier.issn1751-8431
dc.identifier.orcid0000-0002-8299-6926
dc.identifier.orcid0000-0003-1014-8845
dc.identifier.orcid0000-0001-7212-2937
dc.identifier.orcid0000-0003-2552-1403
dc.identifier.pmid41653057
dc.identifier.scopus2-s2.0-105029559692
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1080/17518423.2026.2626754
dc.identifier.urihttps://hdl.handle.net/11508/55325
dc.identifier.wosWOS:001684066600001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofDevelopmental Neurorehabilitation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCerebral palsy
dc.subjectDubousset Functional Test
dc.subjectGross Motor Function
dc.subjectrehabilitation
dc.subjectreliability
dc.titleFunctional motor performance and reliability of the Dubousset Functional Test in ambulatory children with spastic cerebral palsy
dc.typeArticle

Dosyalar